Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?

Sara De Carolis, Silvia Salvi, Antonio Lanzone, Angela Botta, Pasquo E. di, Sordo G. Del, C. Garufi, Carolis M. P. De

Risultato della ricerca: Contributo in rivistaArticolo in rivista

Abstract

The best therapy regimen for refractory obstetrical antiphospholipid syndrome remains to be determined. Additional treatments with steroids, plasma exchanges and immunoglobulins failed to show any beneficial effect. We present a case of a woman who had a better pregnancy outcome after the administration of hydroxychloroquine (HCQ) as additional treatment. Furthermore, we highlighted that HCQ was able to dramatically reduce the antiphospholipid antibodies levels.
Lingua originaleEnglish
pagine (da-a)760-762
Numero di pagine3
RivistaAUTOIMMUNITY REVIEWS
Volume14
DOI
Stato di pubblicazionePubblicato - 2015

Keywords

  • Antibodies, Antiphospholipid
  • Antiphospholipid Syndrome
  • Pregnancy Outcome
  • Pregnancy
  • Pregnancy Complications
  • Hydroxychloroquine

Fingerprint

Entra nei temi di ricerca di 'Is there any role for the hydroxychloroquine (HCQ) in refractory obstetrical antiphospholipid syndrome (APS) treatment?'. Insieme formano una fingerprint unica.

Cita questo